Meperidine Hydrochloride

CHEMBL1701 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

283.8 g/mol

LogP

—

Phase

4

A hydrochloride salt form of meperidine, a short-acting opioid pain reliever used for acute moderate-to-severe pain, typically in hospital settings for procedures or post-surgical pain management.

Masse moléculaire

283,7900 g/mol

TPSA

29,50 Å²

Aires thérapeutiques

Pancreatic Cancer Pain Management Non-Small Cell Lung Cancer Generalized Anxiety Disorder Stroke Obesity Breast Cancer Chronic Pain Hepatitis C

Mécanisme d'action

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission …

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCOC(=O)C1(c2ccccc2)CCN(C)CC1.Cl

InChI

InChI=1S/C15H21NO2.ClH/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13;/h4-8H,3,9-12H2,1-2H3;1H

Molecular Formula

C15H22ClNO2

HBD / HBA

1 / 3

Liaisons Rotatives

4

Atomes Lourds

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A hydrochloride salt form of meperidine, a short-acting opioid pain reliever used for acute moderate-to-severe pain, typically in hospital settings for procedures or post-surgical pain management.

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Yes, Meperidine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1701. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5750. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Meperidine Hydrochloride sur PillFYI

Structure

Données Clés

Formule: C15H22ClNO2
Synonymes: 2

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.